Last updated on 2013-11-22T06:54+0300.
About this image
Extracted quotes from
|Key Titles and Phrases||Count||Lang||Last Seen|
Friday, September 18, 2020
8:20:00 PM EAT
Select your languages
Extracted quotes about
finanznachrichten-en Thursday, June 4, 2020 9:00:00 PM EAT
Thomas Kuhn said ( about David E ) : "During the first quarter, we completed a number of important accomplishments within the Company and for our clinical programs. We strengthened our executive management team with the appointment of David E. Moller, MD, as CSO. As an industry leader in drug development with expertise in type 2 diabetes and metabolic diseases, David is leading activities related to scientific innovation, specifically with adenosine monophosphate-activated protein kinase (AMPK) and mitochondrial pyruvate carrier (MPC). In addition, he is expanding our scientific communications activities through the publication of new data,"
finanznachrichten-en Tuesday, April 21, 2020 7:19:00 PM EAT
Thomas Kuhn commented ( about David E ) : “With an unmatched depth of expertise in metabolic disease research and drug development, David is a valuable addition to Poxel’s senior management team. This is a critical and exciting time for the Company as we support our partners Sumitomo Dainippon Pharma with product registration for Imeglimin in Japan, and Metavant, a subsidiary of Roivant Sciences, with their preparation for a Phase 3 program for Imeglimin in the U.S. and Europe, while advancing our two NASH programs, PXL770 and PXL065, through key clinical studies,”
4-traders Thursday, January 23, 2020 10:30:00 AM EAT